Form 8-K - Current report:
SEC Accession No. 0001641172-25-011999
Filing Date
2025-05-22
Accepted
2025-05-22 09:27:20
Documents
12
Period of Report
2025-05-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35195
  Complete submission text file 0001641172-25-011999.txt   201715

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imnn-20250522.xsd EX-101.SCH 3009
3 XBRL LABEL FILE imnn-20250522_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE imnn-20250522_pre.xml EX-101.PRE 24161
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 25975079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)